SMTL ID : 7zi3.1

Crystal structure of dCK C4S-S74E mutant in complex with UDP and the OR0642 inhibitor

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.90 Å

Oligo State

homo-dimer

Ligands

2 x J98: 2-[2-[[2-methyl-5-[4-(4-methylpiperazin-1-yl)sulfonyl-2-(trifluoromethyl)phenyl]phenyl]-propyl-amino]-1,3-thiazol-4-yl]pyrimidine-4,6-diamine(Non-covalent)

J98.1: 19 residues within 4Å: Chain A: I.50, E.73, V.75, L.102, M.105, Y.106, F.116, Q.117, R.148, D.153, F.157, N.160, L.161, S.164, E.217, I.220, P.221, Y.224, K.227 20 PLIP interactions: 20 interactions with chain A Hydrophobic interactions: A:I.50, A:V.75, A:L.102, A:M.105, A:Y.106, A:Y.106, A:I.220, A:Y.224, A:Y.224 Hydrogen bonds: A:E.73, A:Q.117, A:Q.117, A:R.148, A:D.153, A:N.160, A:S.164, A:K.227 Water bridges: A:R.148 pi-Stacking: A:F.157, A:Y.224 J98.4: 19 residues within 4Å: Chain B: I.50, E.73, V.75, L.102, M.105, Y.106, F.116, Q.117, R.148, D.153, F.157, N.160, L.161, S.164, E.217, I.220, P.221, Y.224, K.227 19 PLIP interactions: 19 interactions with chain B Hydrophobic interactions: B:I.50, B:V.75, B:L.102, B:M.105, B:Y.106, B:Y.106, B:I.220, B:Y.224, B:Y.224 Hydrogen bonds: B:E.73, B:Q.117, B:Q.117, B:R.148, B:N.160, B:S.164, B:K.227 Water bridges: B:R.148 pi-Stacking: B:F.157, B:Y.224

2 x UDP: URIDINE-5'-DIPHOSPHATE(Non-covalent)

UDP.2: 14 residues within 4Å: Chain A: N.49, A.51, A.52, G.53, K.54, S.55, T.56, E.147, R.208, L.211, R.212, D.261, F.262, K.263 21 PLIP interactions: 21 interactions with chain A Hydrophobic interactions: A:F.262 Hydrogen bonds: A:A.51, A:G.53, A:K.54, A:S.55, A:T.56, A:T.56, A:T.56, A:E.147, A:D.261, A:F.262, A:K.263, A:K.263, A:K.263 Water bridges: A:K.54, A:K.54 Salt bridges: A:K.54, A:R.212, A:R.212 pi-Cation interactions: A:R.208, A:K.263 UDP.5: 14 residues within 4Å: Chain B: N.49, A.51, A.52, G.53, K.54, S.55, T.56, E.147, R.208, L.211, R.212, D.261, F.262, K.263 20 PLIP interactions: 20 interactions with chain B Hydrophobic interactions: B:F.262 Hydrogen bonds: B:A.51, B:G.53, B:K.54, B:S.55, B:T.56, B:T.56, B:T.56, B:D.261, B:F.262, B:K.263, B:K.263, B:K.263 Water bridges: B:K.54, B:K.54 Salt bridges: B:K.54, B:R.212, B:R.212 pi-Cation interactions: B:R.208, B:K.263

2 x NA: SODIUM ION(Non-functional Binders)

NA.3: 3 residues within 4Å: Chain A: K.62, S.65, W.68 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:W.68, A:W.68 NA.6: 3 residues within 4Å: Chain B: K.62, S.65, W.68 2 PLIP interactions: 2 interactions with chain B Hydrogen bonds: B:K.62, B:W.68

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Saez-Ayala, M. et al., From a drug repositioning to a structure-based drug design approach to tackle acute lymphoblastic leukemia. Nat Commun (2023)

Release Date

2023-06-07

Peptides

Deoxycytidine kinase: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
A

Deoxycytidine kinase

Related Entries With Identical Sequence